Hospital or health organisation · founded 1913
City of Hope
Lancaster, United States · cityofhope.org/location/antelope-valley
- Citations, last 5 years
- 83.9k
- Works, last 5 years
- 7 099
- h-index
- 595
- Scientists listed
- 36
- Grants since 2016
- 654
Grants received
2019–2024 · research · R01
The role of O-GlcNAcylation in DNA damage repair and cancer therapy
Jeremy Michael Stark · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Precision approaches to refining TP53-associated cancer risk
Christopher I. Amos · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Long non-coding RNA-mediated chromatin remodeling in angiogenesis
Zhen Bouman Chen · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells
Jianhua Yu · City of Hope · funded by National Institutes of Health
2019–2025 · research · R01
Regulation of N6-methyladenosine (m6A) deposition by arginine methylation
Yanzhong Yang · City of Hope · funded by National Institutes of Health
2019–2025 · research · R01
Regulation of beta-cell homeostasis by DNA methylation and hydroxymethylation.
Sangeeta Dhawan · City of Hope · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Optimizing GVHD Prevention with Systems Pharmacology Models
Donald E Mager · City of Hope · funded by National Institutes of Health
2019–2025 · research · R01
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
Christiane Querfeld · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Exploring the preclinical relevance of therapeutic radiolabeled daratumumab (anti-CD38) in combination with anti-CS1 CAR T cells as a novel combinatorial treatment for multiple myeloma
Flavia Pichiorri · City of Hope · funded by National Institutes of Health
2019–2022 · research · R03
Improving Clinical Trial Participation of Older Adults with Cancer
Mina S Sedrak · City of Hope · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Optimizing GVHD Prevention with Systems Pharmacology Models
David A. Horne · City of Hope · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer
Peter Poon-Hang Lee · City of Hope · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Optimizing GVHD Prevention with Systems Pharmacology Models
Jeannine S Mccune · City of Hope · funded by National Institutes of Health
2019–2024 · research · R35
Scalable tools to effectively translate genomic discoveries into the clinic
Stacy W. Gray · City of Hope · funded by National Institutes of Health
2019–2025 · research · R01
The role of O-GlcNAcylation in DNA damage repair and cancer therapy
Jeremy Michael Stark · City of Hope · funded by National Institutes of Health
2019–2024 · research · R35
Scalable tools to effectively translate genomic discoveries into the clinic
Stacy W. Gray · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Long non-coding RNA-mediated chromatin remodeling in angiogenesis
Zhen Bouman Chen · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
The role of O-GlcNAcylation in DNA damage repair and cancer therapy
Jeremy Michael Stark · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
(PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research
Shiuan Chen · City of Hope · funded by National Institutes of Health
2019–2020 · research · R56
Defining the Role of Adipogenesis in Age-Associated Adiposity
Qiong Annabel Wang · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
Christiane Querfeld · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
RECQ5-dependent SUMO2 conjugation of PCNA in the resolution of transcription-replication conflicts
Yilun Liu · City of Hope · funded by National Institutes of Health
2019–2025 · research · R01
Targeting FTO to treat acute myeloid leukemia
Jianjun Chen · City of Hope · funded by National Institutes of Health
2019–2023 · research · R01
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
Behnam Badie · City of Hope · funded by National Institutes of Health
2019–2023 · research · R01
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
Behnam Badie · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Precision approaches to refining TP53-associated cancer risk
Christopher I. Amos · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML
Jianjun Chen · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Targeting FTO to treat acute myeloid leukemia
Jianjun Chen · City of Hope · funded by National Institutes of Health
2019 · grant · Medical Research
Medical Research: City of Hope
Saswati Chatterjee · City of Hope · funded by W. M. Keck Foundation
2019–2021 · research · R21
scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid Leukemia
Jianhua Yu · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
DNA repair gene mutations and prostate cancer
Binghui Shen · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Long non-coding RNA-mediated chromatin remodeling in angiogenesis
Zhen Bouman Chen · City of Hope · funded by National Institutes of Health
2019–2022 · research · R21
A Novel E3 Ubiquitin Ligase for CML Stem Cells
Wenyong Chen · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of N6-methyladenosine (m6A) deposition by arginine methylation
Yanzhong Yang · City of Hope · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer
Peter Poon-Hang Lee · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
Christiane Querfeld · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
Regulating SNARE mechanisms to remediate glucose homeostasis
Debbie C Thurmond · City of Hope · funded by National Institutes of Health
2019–2025 · research · R01
Regulation of N6-methyladenosine (m6A) deposition by arginine methylation
Yanzhong Yang · City of Hope · funded by National Institutes of Health
2019–2021 · research · R03
Characterization of CEACAM1 as a novel therapeutic in mantle cell lymphoma
Vu Nguyen Ngo · City of Hope · funded by National Institutes of Health
2019–2024 · research · R01
The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML
Jianjun Chen · City of Hope · funded by National Institutes of Health